Gender-affirming hormone therapy: principles and monitoring
- Follow-up and treatment
Some transgender and gender-diverse people take hormones so their body matches their gender. Every doctor should know what is monitored and the main risks.
What it is
Gender-affirming hormone therapy uses sex hormones, and sometimes medicines that lower the body's own sex hormones, to develop the physical characteristics that match a person's gender identity. Feminising therapy uses oestradiol, usually with an androgen-lowering medicine; masculinising therapy uses testosterone. It is offered after assessment and informed consent, within specialised care that may also include mental-health support and other services. Monitoring follows the hormone levels and the known risks: thrombosis with oestrogen, erythrocytosis with testosterone, and effects on lipids, liver, prolactin and bone. Fertility options are discussed before starting. Care of adolescents is provided only by specialised multidisciplinary teams, and the rules differ between countries. This page gives principles only, not regimens or doses.
What to know
- Goals: physical changes that match the person's gender and better wellbeing; respectful care uses the person's chosen name and pronouns.
- Feminising effects: breast growth (usually permanent), softer skin, fat redistribution, less muscle, fewer erections and smaller testes, reduced fertility; the voice and established facial hair do not change with hormones.
- Masculinising effects: deeper voice and facial and body hair (usually permanent), clitoral growth, menstruation stops, more muscle, acne and possible scalp hair loss.
- Main risk of oestrogen: venous thromboembolism, higher with smoking, older age, oral oestrogen and previous clots; transdermal routes carry less risk.
- Main risk of testosterone: erythrocytosis (high haematocrit); also acne, lipid changes and raised blood pressure.
- Testosterone does not reliably prevent pregnancy: contraception is still needed if pregnancy is possible.
- Fertility can fall, sometimes permanently: sperm or egg preservation is offered before starting.
- Bone: hormones protect bone when levels are adequate; bone loss is a risk if hormones are stopped after gonadectomy or levels are too low.
- Cancer screening follows the organs a person has: cervical screening with a cervix, breast screening per local guidance, and the prostate remains after feminising therapy.
What is monitored, and why
| Item | Feminising therapy | Masculinising therapy |
|---|---|---|
| Hormone levels | Oestradiol in the typical female range; testosterone suppressed | Testosterone in the typical male range |
| Main safety marker | Thrombosis risk (history, smoking, route) | Haematocrit (erythrocytosis) |
| Other blood tests | Potassium and kidney function with spironolactone; prolactin; lipids; liver tests where relevant | Lipids; liver tests where relevant |
| Blood pressure and weight | Yes | Yes |
| Bone | Density if risk factors, after gonadectomy or if hormones are stopped | Same |
| Organ screening | Breast (per guidance); prostate remains | Cervix and breast if present |
In the clinic
- A person on testosterone with headache and a high haematocrit has erythrocytosis: the team reviews the formulation and levels before anything else, and smoking and sleep apnoea are checked.
- A person on oestradiol with a swollen calf is assessed for deep vein thrombosis exactly as anyone else would be; stopping smoking is the single best way to lower the risk.
- Any doctor can provide general care, take a respectful history, and keep screening up to date for the organs present.
- In Colombia, gender-affirming care is provided within the health system by specialised teams; general practitioners refer and coordinate.
Next step / Initial management
- Before starting: baseline blood count, lipids, glucose or HbA1c, liver and kidney tests, prolactin where relevant, hormone levels, blood pressure and thrombosis risk assessment.
- During treatment: hormone levels, haematocrit on testosterone, potassium with spironolactone, prolactin with oestrogen where relevant, lipids and liver tests periodically, as set by the specialist team.
- Assess bone density when there are risk factors, after gonadectomy or if hormones are interrupted.
- Offer fertility counselling and preservation before starting, and contraception counselling when pregnancy is possible.
- Refer to a specialised gender care team for starting or adjusting therapy, for all adolescents, and for thrombosis, erythrocytosis or other complications; this page gives no regimens or doses.
Common traps
- Hormone therapy is the same for everyone and needs no follow-up: the effect and the risks depend on the person and the hormone, which is why levels, haematocrit, potassium and other markers are monitored.
- Testosterone works as a contraceptive: ovulation can continue, so a person with a uterus and ovaries on testosterone can become pregnant and needs contraception.
- Fertility can be thought about later: hormones can reduce fertility, sometimes permanently, so options are discussed before starting.
- A transgender woman no longer needs prostate care: feminising hormones and most surgeries leave the prostate in place, so it is still considered.
- Gender-affirming care is only for specialists: every clinician can provide respectful general care, organ-based screening and recognise complications such as thrombosis and erythrocytosis.
Test yourself
Think of the answer, then tap the question to see it.
A 30-year-old on testosterone has a haematocrit above the upper limit and morning headaches. What complication is this and what does the team review?
Erythrocytosis from testosterone: the team reviews hormone levels and formulation and looks for smoking or sleep apnoea, as these add to the rise.
A 45-year-old smoker on oral oestradiol asks how to make her therapy safer. What is the main risk and the most important step?
Venous thromboembolism: stopping smoking lowers it most; the specialist team may also consider a transdermal route.
A transgender man on testosterone, with a uterus and ovaries, says he cannot get pregnant. Is he right?
No: testosterone does not reliably stop ovulation, so pregnancy is possible and contraception is needed.
Which conversation must happen before any gender-affirming hormones are started, and why?
Fertility counselling with the option of sperm or egg preservation, because hormones can reduce fertility, sometimes permanently.
Elsewhere in DurgiPedia
- Testosterone and its actions
- Actions of estrogen and progesterone
- Fertility preservation
- The adolescent visit: confidentiality, HEADSSS and normal puberty
- A high haemoglobin: relative, secondary or polycythaemia vera?
- Thrombosis and Virchow's triad
Connections
Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.
Sources: Gender Dysphoria (StatPearls (NCBI Bookshelf), 2023); Estradiol (StatPearls (NCBI Bookshelf), 2023); Physiology, Testosterone (StatPearls (NCBI Bookshelf), 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
